Chemoinformaics analysis of 5-Methoxy-N-methyltryptamine
Molecular Weight | 204.273 | nRot | 4 |
Heavy Atom Molecular Weight | 188.145 | nRig | 10 |
Exact Molecular Weight | 204.126 | nRing | 2 |
Solubility: LogS | -1.416 | nHRing | 1 |
Solubility: LogP | 1.827 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
No. of Oxygen atom | 1 | No. of Arom Bond | 10 |
nHA | 2 | APOL | 33.7107 |
nHD | 2 | BPOL | 18.9273 |
QED | 0.798 |
Synth | 1.975 |
Natural Product Likeliness | -0.03 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.488 |
HIA | 0.005 |
CACO-2 | -4.756 |
MDCK | 0.00000762 |
BBB | 0.839 |
PPB | 0.301843 |
VDSS | 3.084 |
FU | 0.591347 |
CYP1A2-inh | 0.603 |
CYP1A2-sub | 0.948 |
CYP2c19-inh | 0.079 |
CYP2c19-sub | 0.739 |
CYP2c9-inh | 0.013 |
CYP2c9-sub | 0.873 |
CYP2d6-inh | 0.866 |
CYP2d6-sub | 0.934 |
CYP3a4-inh | 0.114 |
CYP3a4-sub | 0.22 |
CL | 8.037 |
T12 | 0.709 |
hERG | 0.346 |
Ames | 0.146 |
ROA | 0.831 |
SkinSen | 0.918 |
Carcinogencity | 0.031 |
EI | 0.048 |
Respiratory | 0.97 |
NR-Aromatase | 0.006 |
Antiviral | No |
Prediction | 0.629278 |